Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non (Q44337354)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non |
scientific article |
Statements
1 reference
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non (English)
1 reference
Bart Morlion
1 reference
Lynn Webster
1 reference
Jan Peter Jansen
1 reference
John Peppin
1 reference
Ben Lasko
1 reference
Gordon Irving
1 reference
Jerry Snidow
1 reference
Amy Pierce
1 reference
Eric Mortensen
1 reference
Christi Kleoudis
1 reference
Eric Carter
1 reference
31 December 2007
1 reference
Identifiers
1 reference